Exact Sciences Co. (NASDAQ:EXAS) Receives $96.18 Average Pri

Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12-month price […]

Related Keywords

United States , America , Brian Baranick , Piper Sandler , James Edward Doyle , Victory Capital Management Inc , News Ratings For Exact Sciences Daily , Sciences Stock Performance , Sciences Corporation , Sciences Co , Assetmark Inc , Securities Exchange Commission , Credit Suisse Group , Columbus Asset Advisors , Insider Transactions At Exact Sciences , Jefferies Financial Group , Global Retirement Partners , Analyst Recommendations For Exact Sciences , Nasdaq , Exact Sciences , Get Free Report , Financial Group , Suisse Group , Director James Edward Doyle , Exchange Commission , Retirement Partners , Capital Management , Get Free , Recurrence Score Test , Score Test , Oncoextra Test , Exact Sciences Daily , Nasdaq Exas , Texas , Medical , 30063p10 , Ratings , Consensus ,